Opinion - Page 21

WASHINGTON — Tracy Beth Høeg, the top drug regulator at the Food and Drug Administration, indicated in her first address to staff that she’ll scrutinize antidepressants and the shots used to protect

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. Yesterday was another historic day for us because STAT — specifically the

In his 1694 review of magnifying lens technology, “Essai de Dioptrique,” Dutch naturalist Nicolas Hartsoeker included a drawing destined to make a lasting impression on future students of human reproduction. Inside a

It makes my head spin to think about how much GLP-1s have changed the medical weight management landscape in such a short time. In 2023, I wrote for STAT about GLP-1 shortages

WASHINGTON — Federal officials have missed the legal deadline to notify the public of an upcoming meeting of a vaccine advisory panel that was planned for next week, raising questions about whether

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. Before Robert F. Kennedy Jr. became federal health secretary, he had a

Through a microscope, pathologists can see a great deal about a tumor. They can diagnose the disease, and get a sense for how aggressive it may be. But human eyes are limited

JEFFERSON CITY, Mo. — Agrochemical maker Bayer and attorneys for cancer patients announced a proposed $7.25 billion settlement Tuesday to resolve thousands of U.S. lawsuits alleging the company failed to warn people

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. I finished shoveling out my car this weekend — I even drove

Compass Pathways on Tuesday disclosed results from two Phase 3 studies that support a potential approval of its psilocybin treatment for severe depression, but more detailed data are needed to determine how